Nath Bio-Genes (India) News
- Market cap
- ₹261 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹98.91 – ₹185.45
The latest update on Nath Bio-Genes (India) is "Nath Bio-Genes (India) Limited Reports Operational Performance & Quarterly Growth Update" (BSE Corporate Announcement), published 9 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE. Nath Bio-Genes (India)'s next board meeting for results is scheduled for 3 November 2026.
Latest Nath Bio-Genes (India) news and announcements
Next results board meeting: 3 November 2026.
- Nath Bio-Genes (India) Limited Reports Operational Performance & Quarterly Growth Update
- Market Activity: Nath Bio-Genes (India) Limited Shares See Strong Institutional Volume
- Nath Bio-Genes (India) Limited Board Compliances & Mandatory Disclosure Filings Submitted
- Analyst Review: Key Valuation Overview & Target Projection for Nath Bio-Genes (India) Limited
Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 9 October 2026. How this data is compiled.
Nath Bio-Genes (India) news & announcements — frequently asked questions
What is the latest news on Nath Bio-Genes (India)?
The most recent item is "Nath Bio-Genes (India) Limited Reports Operational Performance & Quarterly Growth Update" from BSE Corporate Announcement on 9 October 2026. The full list above links to each original source.
When are Nath Bio-Genes (India)'s next results?
Nath Bio-Genes (India) has announced a board meeting on 3 November 2026 to consider its financial results, according to its filing on BSE.
Where do these Nath Bio-Genes (India) headlines come from?
Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.
Same Data For Peers
Trade Nath Bio-Genes (India) With ATS
Track NATHBIOGEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.